Utility of levosimendan, a new calcium sensitizing agent, in the treatment of cardiogenic shock due to myocardial stunning in patients with ST-elevation myocardial infarction: a series of cases.
García-González
Martín J
MJ
Coronary Care Unit, Department of Cardiology, Hospital Universitario de Canarias, Tenerife, Spain.
Domínguez-Rodríguez
Alberto
A
Ferrer-Hita
Julio J
JJ
D000368:Aged; D015906:Angioplasty, Balloon, Coronary / Q000379:methods; D001281:Atrial Fibrillation / Q000150:complications / Q000628:therapy; D002121:Calcium Channel Blockers / Q000737:chemistry / Q000627:therapeutic use*; D002316:Cardiotonic Agents / Q000627:therapeutic use*; D004562:Electrocardiography; D006801:Humans; D006835:Hydrazones / Q000627:therapeutic use*; D007423:Intra-Aortic Balloon Pumping / Q000379:methods; D008875:Middle Aged; D009203:Myocardial Infarction / Q000150:complications*; D017682:Myocardial Stunning / Q000150:complications*; D010493:Pericarditis / Q000150:complications; D011724:Pyridazines / Q000627:therapeutic use*; D012121:Respiration, Artificial / Q000379:methods; D012770:Shock, Cardiogenic / Q000188:drug therapy* / Q000209:etiology; D000077464:Simendan; D018487:Ventricular Dysfunction, Left / Q000150:complications
D002121:Calcium Channel Blockers; D002316:Cardiotonic Agents; D006835:Hydrazones; D011724:Pyridazines; D000077464:Simendan